Early identification and standardised clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing, and pathological evaluation. The platform can assist in matching teams of nationally and internationally authoritative experts to provide accurate diagnosis and treatment plans.
Treatment plans for treatment and management of progenitor cell cancer require individualized management, typically including drug therapy, rehabilitation, regular follow-up, and multi-dimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the previously difficult autoimmune and rheumatic immune disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely regimens according to changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Bowen's stem cell cancer. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.